American International Group, Inc. Chembio Diagnostics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.88 - $5.64 $33,160 - $64,938	-11,514 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.4 - $7.97 $105 - $247	31 Added 0.27%	11,514 $40,000
Q4 2020 Feb 12, 2021	SELL	$4.11 - $7.51 $1,352 - $2,470	-329 Reduced 2.79%	11,483 $55,000
Q3 2020 Nov 04, 2020	SELL	$3.28 - $5.93 $344 - $622	-105 Reduced 0.88%	11,812 $57,000
Q2 2020 Aug 12, 2020	BUY	$3.18 - $15.54 $37,896 - $185,190	11,917 New	11,917 $39,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.